Richmond Pharmacology exhibits at industry events

Posted:

April 2004

Spring has been a busy time for Richmond Pharmacology with exhibition presence at two major industry events.Claire Tucker, Business Development Manager, and Jonathan McCarron, Sales Manager, travelled to Prague in March to exhibit at the 16th Annual EuroMeeting organised by the Drug Information Association (DIA).The meeting and exhibition were very well attended by a wide range of international delegates. It was an excellent opportunity for us to meet up with our clients and make some new contacts.The industry gathered together once again on 6th & 7th April for the 25th Annual Spring Meeting and Exhibition, held by the Institute of Clinical Research (ICR). Richmond Pharmacology’s bright orange stand couldn’t be missed!

Back to news

More about us Adaptive Phase I & IIa Bridging Studies TQT Studies Patient Recruitment

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Latest Publications

View our latest peer-reviewed publications from a selection of our clinical trials.

Latest Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020

Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.

View event

COVID-19 – External Monitoring Guidelines

July 1, 2020

Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.

First transdermal patch to treat schizophrenia hits market

March 18, 2020

The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful

Statement: COVID-19

March 23, 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.